opc 12759 has been researched along with interleukin-8 in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aihara, M; Azuma, A; Funakoshi, Y; Imagawa, K; Kikuchi, M; Matsushima, K; Mukaida, N; Ohmoto, Y; Shindo, Y; Takizawa, H; Tsuchimoto, D | 1 |
| Hong, KW; Kim, CD; Kim, HH | 1 |
| Kim, H; Kim, KH; Seo, JY | 1 |
| Haruma, K; Kishimoto, S; Nakagawa, Y; Nakano, M; Sakurai, K; Tari, A | 1 |
| Masamune, A; Sakai, Y; Shimosegawa, T; Yoshida, M | 1 |
| Choi, KW; Choi, MG; Chung, IS; Chung, MH; Hahm, KB; Hong, WS; Jung, HY; Kim, JG; Kim, JH; Kim, NY; Kim, SW; Lee, JJ; Lee, SW; Lee, YC; Roe, IH | 1 |
| Haixia, C; Jie, L; Qi, Z; Xiaoying, Z | 1 |
| Choi, JH; Choi, KU; Hong, KW; Jeon, TY; Kim, CD; Kim, DW; Kim, GH; Kim, JY; Kim, WK; Lee, KH; Lee, SH; Lee, WJ; Park, DY; Shin, DH; Song, GA | 1 |
| Choe, JY; Kim, SK; Lee, SJ; Park, KY; Park, SH | 1 |
| Fukuda, K; Fukushima, A; Harada, Y; Ishida, W; Tanaka, H | 1 |
1 trial(s) available for opc 12759 and interleukin-8
| Article | Year |
|---|---|
Effect of rebamipide in treatment of Helicobacter pylori-associated duodenal ulcer: attenuation of chemokine expression and nitrosative damage.
Topics: Adult; Alanine; Antioxidants; Chemokine CCL5; Cytokines; Drug Therapy, Combination; Duodenal Ulcer; Enzyme-Linked Immunosorbent Assay; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Interleukin-1; Interleukin-8; Male; Quinolones; Tumor Necrosis Factor-alpha; Tyrosine | 2002 |
9 other study(ies) available for opc 12759 and interleukin-8
| Article | Year |
|---|---|
Molecular analysis of suppression of interleukin-8 production by rebamipide in Helicobacter pylori-stimulated gastric cancer cell lines.
Topics: Alanine; Anti-Ulcer Agents; Blotting, Northern; DNA Primers; Gene Expression Regulation, Neoplastic; Helicobacter pylori; Humans; Interleukin-8; Quinolones; RNA, Messenger; Stomach Neoplasms; Tumor Cells, Cultured | 1998 |
Inhibitory effect of rebamipide on the neutrophil adherence stimulated by conditioned media from Helicobacter pylori-infected gastric epithelial cells.
Topics: Alanine; Anti-Ulcer Agents; Antibodies; Cell Adhesion; Culture Media, Conditioned; Cytokines; Epithelial Cells; Gastric Mucosa; Helicobacter pylori; Humans; Interleukin-8; Macrophage-1 Antigen; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Polymerase Chain Reaction; Quinolones; RNA, Messenger; Tumor Cells, Cultured | 1999 |
Inhibition of lipid peroxidation, NF-kappaB activation and IL-8 production by rebamipide in Helicobacter pylori-stimulated gastric epithelial cells.
Topics: Alanine; Anti-Ulcer Agents; Cells, Cultured; Cytokines; Epithelial Cells; Free Radical Scavengers; Gastric Mucosa; Helicobacter pylori; Humans; Interleukin-8; Lipid Peroxidation; NF-kappa B; Quinolones | 2000 |
Rebamipide, an antiulcer drug, prevents DSS-induced colitis formation in rats.
Topics: Alanine; Animals; Anti-Ulcer Agents; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Interleukin-1; Interleukin-8; Male; Peroxidase; Quinolones; Rats; Rats, Wistar | 2000 |
Rebamipide inhibits ceramide-induced interleukin-8 production in Kato III human gastric cancer cells.
Topics: Alanine; Anti-Ulcer Agents; Blotting, Northern; Blotting, Western; Ceramides; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Gastric Mucosa; Gene Expression Regulation, Neoplastic; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-8; Mitogen-Activated Protein Kinases; NF-kappa B; Quinolones; Signal Transduction; Stomach Neoplasms; Tumor Cells, Cultured | 2001 |
Effect of rebamipide on quality of peptic ulcer healing in rat.
Topics: Alanine; Animals; Anti-Ulcer Agents; Dinoprostone; Drug Therapy, Combination; Gastric Mucosa; Interleukin-8; Male; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Quinolones; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Stomach; Ultrasonography | 2009 |
Protective effect of rebamipide against Helicobacter pylori-CagA-induced effects on gastric epithelial cells.
Topics: Alanine; Animals; Anti-Ulcer Agents; Antigens, Bacterial; Antioxidants; Bacterial Proteins; Cell Line; Dogs; Epithelial Cells; Humans; Interleukin-8; Membrane Proteins; NF-kappa B; Phosphoproteins; Quinolones; Stomach; Time Factors; Zonula Occludens-1 Protein | 2011 |
Rebamipide inhibits tumor necrosis factor-α-induced interleukin-8 expression by suppressing the NF-κB signal pathway in human umbilical vein endothelial cells.
Topics: Active Transport, Cell Nucleus; Alanine; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Inhibitors; Humans; I-kappa B Proteins; Interleukin-8; NF-KappaB Inhibitor alpha; Phosphorylation; Quinolones; Signal Transduction; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Umbilical Veins | 2010 |
Inhibition by rebamipide of cytokine-induced or lipopolysaccharide-induced chemokine synthesis in human corneal fibroblasts.
Topics: Alanine; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Chemokine CCL11; Corneal Keratocytes; Corneal Stroma; Enzyme-Linked Immunosorbent Assay; Humans; I-kappa B Kinase; Interleukin-8; Lipopolysaccharides; Quinolones; Real-Time Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha | 2014 |